KOLINPHARMA
I prodotti Kolinpharma
News
From Kolinpharma world
10/03/2020
KOLINPHARMA® obtains the patent in the U.S. of Dolatrox®

Dolatrox® is the composition for the treatment of arthropathies and osteoarthritis, as stated in the patent certificate, for which the characteristics of innovation and uniqueness have been recognized. For an action aimed at maintaining the normal cartilage structure.

"Obtaining the fourth patent, in a country like the United States, a worldwide reference in scientific research, is a huge source of pride for us" - comments the president, Rita Paola Petrelli.

Research and innovation, with KOLINPHARMA®, always alongside people's well-being.


< Back
Ultime news
From confusion to clarity: why Italy must establish specific guidelines for nutraceuticals. Kolinpharma®'s proposal.
17/07/2025
From confusion to clarity: why Italy must establish specific guidelines for nutraceuticals. Kolinpharma®'s proposal.
Kolinpharma® receives new award, the “America Innovation” award, from Fondazione Italia Usa
22/03/2025
Kolinpharma® receives new award, the “America Innovation” award, from Fondazione Italia Usa
Metatag
Respect the environment, Certified products, Corporate compliance, Dolatrox, Nutraceuticals , Profile and organization, Research and development, Consumer Protection
“Science accuracy and listen to people”
“Science accuracy and listen to people”